Blood Test for Patients on Acne Medication Deemed Unnecessary
For young, healthy women taking spironolactone, potassium monitoring may be an unnecessary expense. (Source: BWH News)
Source: BWH News - March 22, 2015 Category: Hospital Management Source Type: news
Blood Test for Patients on Acne Medication Deemed Unnecessary
For young, healthy women taking spironolactone, potassium monitoring may be an unnecessary expense. (Source: BWH for Journalists)
Source: BWH for Journalists - March 22, 2015 Category: Research Source Type: news
Blood Test for Patients on Acne Medication Deemed Unnecessary
For young, healthy women taking spironolactone, potassium monitoring may be an unnecessary expense. (Source: BWH News)
Source: BWH News - March 22, 2015 Category: Hospital Management Source Type: news
Antibiotic, Spironolactone Combo Ups Sudden Death in Elderly Antibiotic, Spironolactone Combo Ups Sudden Death in Elderly
When combined with spironolactone, a diuretic, trimethoprim-sulfamethoxazole is riskier than other antibiotics in people older than 65 years. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 3, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Commonly used antibiotics with diuretic can double risk of sudden death in older patients
The combination of the commonly prescribed antibiotic trimethoprim-sulfamethoxazole with the diuretic spironolactone, widely used for heart failure, more than doubles the risk of death for older patients, reports a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 2, 2015 Category: Science Source Type: news
Certain Heart Drug, Antibiotic Combo Might Be Fatal for Seniors
Doctors should not prescribe spironolactone with trimethoprim-sulfamethoxazole, study saysSource: HealthDay
Related MedlinePlus Pages: Drug Reactions, Medicines, Seniors' Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 2, 2015 Category: Consumer Health News Source Type: news
Effect of Mineralocorticoid Receptor Blockade in T2DEffect of Mineralocorticoid Receptor Blockade in T2D
Does spironolactone prevent heart disease in patients with type 2 diabetes? Diabetes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2015 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
7 Reasons Women Lose Their Hair -- And 7 Treatments
Your ponytail is shrinking...or your part's getting wider...or there's more hair in the shower drain. Take heart -- you're not alone. According to New York City dermatologist Neil Sadick, MD, up to 80 percent of women will have some hair thinning in their lifetime, even if only temporarily. It's normal to shed 50 to 100 hairs a day, says NYC dermatologist Doris Day, MD. If you're losing more than that, a doctor's visit is in order. Here are some common causes and treatments.
Cause: Genetics (the most likely culprit)
Treatment: Minoxidil, the only topical ingredient that's FDA approved to regrow hair in women. Rogaine ha...
Source: Healthy Living - The Huffington Post - January 26, 2015 Category: Consumer Health News Source Type: news
Is Spironolactone a 'Savior' for Hemodialysis Patients?Is Spironolactone a 'Savior' for Hemodialysis Patients?
A new study found that spironolactone significantly reduced the risk for cardiovascular and cerebrovascular morbidity and death in hemodialysis patients, reports Dr Jeffrey Berns. Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 22, 2014 Category: Consumer Health News Tags: Nephrology Commentary Source Type: news
TOPCAT Analysis: Spironolactone Benefits HFPEF in Americas TOPCAT Analysis: Spironolactone Benefits HFPEF in Americas
A new post hoc analysis questions whether many patients entered into the trial in Russia and Georgia actually had heart failure. Heartwire (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 26, 2014 Category: Cardiology Tags: Cardiology News Source Type: news
As Used, Spironolactone Doesn't Cut 30-Day HF ReadmissionsAs Used, Spironolactone Doesn't Cut 30-Day HF Readmissions
It's probably a reflection of a long-recognized problem, say researchers; patients in clinical practice just aren't a lot like those in clinical trials. Heartwire (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 15, 2014 Category: Cardiology Tags: Cardiology News Source Type: news
spironolactone, Aldactone
Title: spironolactone, AldactoneCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/6/2014 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 6, 2014 Category: Cardiology Source Type: news
Spironolactone in Heart Failure? Yes, and Here's WhySpironolactone in Heart Failure? Yes, and Here's Why
Dr. Piña reviews a subgroup analysis from the TOPCAT trial, and explains why she thinks spironolactone has a role in many patients with heart failure. theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2014 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
Hyperkalemia Evident with Spironolactone in Resistant HTNHyperkalemia Evident with Spironolactone in Resistant HTN
A small study finds that 8% of resistant-hypertension patients treated with spironolactone developed hyperkalemia, including one who presented to the emergency department. Researchers advise doctors to monitor potassium levels when using the drug. Heartwire (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - May 20, 2014 Category: Urology & Nephrology Tags: Cardiology News Source Type: news
Clinicians urged to consider spironolactone in HFPEF despite TOPCAT results
Clinicians have been urged to consider using spironolactone in their patients with heart failure and preserved ejection fraction (HFPEF) after a post-hoc analysis of the TOPCAT trial showed benefit in patients from the Americas. TOPCAT randomized 3445 patients with HFPEF to receive spironolactone, a mineralocorticoid receptor antagonist, at a dose of 15-45mg per day or placebo on top of usual care. Patients were recruited from 270 medical centres in 6 countries. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2014 Category: Science Source Type: news
